By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sigma-Tau Group 

9841 Washingtonian Boulevard
Suite 500
Gaithersburg  Maryland  20878  U.S.A.
Phone: 301-948-1041 Fax: 301-948-1862


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Dyax Corp.  Ecallantide in HAE and other therapeutic indications





Company News
Sigma-Tau Group : A New Efficient and Cost Effective Dialysis for Patients With End Stage Renal Disease 6/18/2013 12:21:31 PM
SciClone Pharmaceuticals, Inc. (SCLN) Files S-3 Registration Statement Prospectus Supplement Related to Sigma-Tau Group Transaction 4/30/2012 8:49:39 AM
Dyax Corp. (DYAX) and Sigma-Tau Group Expand Agreement to Commercialize KALBITOR(R) (ecallantide) for Hereditary Angioedema 1/12/2011 10:16:40 AM
Dyax Corp. (DYAX) and Sigma-Tau Group Expand Agreement to Commercialize KALBITOR(R) (ecallantide) for Hereditary Angioedema 1/11/2011 10:58:48 AM
Enzon Pharmaceuticals, Inc. (ENZN) Stockholders Approve Sale of Specialty Pharmaceutical Business to Sigma-Tau Group 1/28/2010 9:05:14 AM
SciClone Pharmaceuticals, Inc. (SCLN) and Sigma-Tau Group Announce Positive Preliminary Results in Clinical Study Examining ZADAXIN'S Ability to Enhance Response to H1N1 Vaccine 1/12/2010 11:40:59 AM
Gentium S.p.A. Announces Extension of License and Supply and Cost Sharing Agreements with Sigma-Tau Group 1/11/2010 9:42:03 AM
SciClone Pharmaceuticals, Inc. (SCLN) Announces Commencement and Complete Enrollment of Clinical Study Examining ZADAXIN's Ability to Enhance the H1N1 Vaccine Led by European Partner, Sigma-Tau Group 12/1/2009 11:20:40 AM
Enzon Pharmaceuticals, Inc. (ENZN) to Sell Specialty Pharmaceuticals Business to the Sigma-Tau Group for $300 Million Plus up to $27 Million 11/9/2009 7:47:07 AM
//-->